BRIEF-Oxford Researchers Identify Levels Of Antibody Protection Required To Prevent Symptomatic COVID-19

OXFORD UNIVERSITY: * OXFORD UNIVERSITY - OXFORD RESEARCHERS IDENTIFY LEVELS OF ANTIBODY PROTECTION REQUIRED TO PREVENT SYMPTOMATIC COVID-19

* OXFORD - HIGHER LEVELS OF ANTI-SPIKE, ANTI-RBD IGG, AND & ANTIBODY TITRES WERE ASSOCIATED WITH GREATER DEGREE OF PROTECTION AGAINST COVID-19 * OXFORD - RESEARCHERS COMPARED ANTIBODY LEVELS IN VACCINE RECIPIENTS 28 DAYS AFTER 2ND DOSE, & COVID CASES THAT OCCURRED OVER 7 DAYS AFTER BLOOD SAMPLE TAKEN

* OXFORD-STUDY CONFIRMS PRIOR INDICATIONS NO SINGLE LEVEL ON ANY BINDING/NEUTRALISING ANTIBODY ASSAYS USED, THAT GIVES FULL PROTECTION AGAINST COVID-19 * OXFORD - RESULTS LINK IMMUNE RESPONSES TO EXPECTED PROTECTION AFTER 2 DOSES, BUT NOT TO CHECK PROTECTION OF A VACCINATED PERSON OR 1 DOSE PROTECTION Further company coverage: [ ]

Also Read: Quad's commitment to provide 1 bn vaccines to people in SE Asia on track: WH official

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)